Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | KUMAR AND BROTHERS | 1 | ₹1,992 |
| 2 | Schedule 2 | VANDANA MEDICO TRADERS | 1 | ₹1,291.50 |
| 3 | Schedule 3 | KUMAR AND BROTHERS | 1 | ₹23,059.50 |
| 4 | Schedule 4 | KUMAR AND BROTHERS | 1 | ₹3,616.20 |
| 5 | Schedule 5 | RITESH HEALTHCARE | 1 | ₹22,500 |
Tender Value
₹2.7 L
EMD Value
Exempted
Closing Date
16 May 2024, 7:00 pmClosed
Lithium Carbonate 300 Mg Cap/Tab
Lotepredenol Etabonate 0.5% Bott Of 5ml E/D
MDI LEVOSALBUTAMOL 50 MCG 200 MD
Mebeverine 135 Mg Tab
Mesalamine 500mg Tab
METHOTREXATE 7.5 MG TAB
Methylprednisolone 16Mg Tab
Metolazone 5 Mg Tab
Metronidazole 400mg Tab
MIDODRINE 2
5 MG TAB
NINTEDANIB 100MG CAP
NINTEDANIB 150 MG CAP
NORMAL SALINE
OFLOXACIN+ ORNIDAZOLE SYRUP
OINT BECLOMETHASONE+ SALISYLIC ACID
Olanzapine 10 Mg Tab
Olanzapine 5 Mg Tab
6300853
GEM/2024/B/4850996
Two Packet Bid
Lithium Carbonate 300 mg Cap/Tab,Lotepredenol Etabonate 0.5% Bott of 5ml E/D,MDI LEVOSALBUTAMOL 50
30 days
Punjab; Amritsar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Lithium Carbonate 300 Mg Cap/Tab | AMRITSAR | 600 | 30 days | |
| Lotepredenol Etabonate 0.5% Bott Of 5ml E/D | AMRITSAR | 30 | 30 days | |
| MDI LEVOSALBUTAMOL 50 MCG 200 MD | AMRITSAR | 150 | 30 days | |
| Mebeverine 135 Mg Tab | AMRITSAR | 1,470 | 30 days | |
| Mesalamine 500mg Tab | AMRITSAR | 3,000 | 30 days | |
| METHOTREXATE 7.5 MG TAB | AMRITSAR | 3,000 | 30 days | - |
| Methylprednisolone 16Mg Tab | AMRITSAR | 3,900 | 30 days | |
| Metolazone 5 Mg Tab | AMRITSAR | 1,500 | 30 days | |
| Metronidazole 400mg Tab | AMRITSAR | 6,300 | 30 days | |
| MIDODRINE 2, 5 MG TAB | AMRITSAR | 900 | 30 days | |
| NINTEDANIB 100MG CAP | AMRITSAR | 540 | 30 days | |
| NINTEDANIB 150 MG CAP | AMRITSAR | 90 | 30 days | |
| NORMAL SALINE | AMRITSAR | 135 | 30 days | - |
| OFLOXACIN+ ORNIDAZOLE SYRUP | AMRITSAR | 60 | 30 days | |
| OINT BECLOMETHASONE+ SALISYLIC ACID | AMRITSAR | 1,350 | 30 days | |
| Olanzapine 10 Mg Tab | AMRITSAR | 7,200 | 30 days | |
| Olanzapine 5 Mg Tab | AMRITSAR | 7,500 | 30 days |
Exempted
16 May 2024
25 Apr 2024
16 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6300853.pdf
GEM_BID
re-12_2024-04-09-09-52-57_da1868452c3af5e7ea981a551b872922.pdf
SPECIFICATION
re-12_2024-04-09-09-53-19_118b18a93983a16272e823fe810a6adf.pdf
SPECIFICATION
re-12_2024-04-09-09-53-40_9b1570858c1212631e8329c699927c73.pdf
SPECIFICATION
re-12_2024-04-09-09-54-01_96d8850c96afd933dd171e5cd32ee073.pdf
SPECIFICATION
re-12_2024-04-09-09-54-42_bed7d0d20e868ef4804118bb751da6e1.pdf
SPECIFICATION
re-12_2024-04-09-09-57-01_9efd665a82cb14ed9d13b5fc11cf73dc.pdf
SPECIFICATION
re-12_2024-04-09-09-57-42_7bb67f10a66b162e243a13051df02207.pdf
SPECIFICATION
re-12_2024-04-09-09-58-04_deae1ef82bba3e6f9a823f9491a1cc95.pdf
SPECIFICATION
re-12_2024-04-09-09-58-29_6d72a59144893e42156bdf5cc23952a3.pdf
SPECIFICATION
re-12_2024-04-09-09-58-57_d7d1e46e944b45bc2499724b2e5c55c4.pdf
SPECIFICATION
re-12_2024-04-09-09-59-19_563b13022cfb3fee442b7ccf748b20f1.pdf
SPECIFICATION
re-12_2024-04-09-10-00-50_020c7d47f65455cb9471e7377b55923b.pdf
SPECIFICATION
re-12_2024-04-09-10-01-14_ee4e0ff5fe11e0b5d4e4a80e672aecbb.pdf
SPECIFICATION
re-12_2024-04-09-10-01-43_3cd1dddc11cc5c3339ee0972fb003186.pdf
SPECIFICATION
re-12_2024-04-09-10-02-51_c99350ba122701d318fb38b29774cfe9.pdf
SPECIFICATION
re-12_2024-04-09-10-03-13_bd001abe7ca2f8b3859da22097e780ca.pdf
SPECIFICATION
re-12_2024-04-09-10-03-35_18de996b41100913ecbee16d7584f953.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .